Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel: +47 21 07 81 60
E-mail:

Copyright/Disclaimer

New DDDs 2020

New ATC codes 2020
ATC/DDD alterations 2020

ATC code	ATC level name	New DDD



A04AD11	nabilone	3	mg	O
A10BJ06	semaglutide	0.11	mg	P
A16AB17	cerliponase alfa	21	mg	P
A16AX09	glycerol phenylbutyrate	15	g	O
G03XX01	prasterone	6.5	mg	V
G04BX15	pentosan polysulfate sodium	0.3	g	O
J01AA14	sarecycline	0.1	g	O
J01AA15	omadacycline	0.3	g	O
J01AA15	omadacycline	0.1	g	P
J01DD64	cefpodoxime and beta-lactamase inhibitor	0.4 ¹⁾	g	O
J01MA12	levofloxacin	0.24	g	Inhal.solution
J04AA03	calcium aminosalicylate	15	g	O
J04AB06	enviomycin	1	g	P
J05AB03	vidarabine	0.7	g	P
J05AG06	doravirine	0.1	g	O
J05AH03	peramivir	0.6	g	P
J05AH04	laninamivir	40	mg	Inhal.powder
J05AP06	asunaprevir	0.2	g	O
J05AP10	elbasvir	50	mg	O
J05AP11	grazoprevir	0.1	g	O
J05AX25	baloxavir marboxil	40	mg	O
J05AX26	amenamevir	0.4	g	O
J05AX27	favipiravir	1.6	g	O
L02BB05	apalutamide	0.24	g	O
L04AB07	opinercept	7	mg	P
L04AC12	brodalumab	15	mg	P
M03BX03	pridinol	6	mg	O
M04AB05	lesinurad	0.2	g	O
N02CD01 ²⁾	erenumab	2.5	mg	P
N02CD02 ³⁾	galcanezumab	4	mg	P
N02CD03	fremanezumab	7.5	mg	P
P01CA03	fexinidazole	1.44	g	O
V03AE10	sodium zirconium cyclosilicate	7.5	g	O

1) Refers to cefpodoxime
2) Previous ATC code N02CX07, new ATC 4th level N02CD valid from January 2020
3) Previous ATC code N02CX08, new ATC 4th level N02CD valid from January 2020.

Last updated: 2019-12-13